Full Length Research Paper
References
Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T (2014). Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid. Based. Child Health 3:584-671. |
|
Banupriya B, Biswal N, Srinivasaraghavan R, Narayanan P, Mandal J (2015). Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial. Intensive Care Med. 41:677-685. |
|
Besselink MGH, van Santvoort HC, Buskens E, et al (2008). Probiotic prophylaxis in predicted severe acute pancreatitis: a randomized, double-blind, placebo-controlled trial. Lancet. 371:651-659. |
|
Brandtzaeg P (1992). Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections. J. Infect. Dis. 165:167-176. |
|
Caceres P, Montes S, Vega N, Cruchet S, Brunser O, Gotteland M (2010). Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. J. Pediatr. Infect. Dis. 5 (4):353-362. |
|
Cernada M, Brugada M, Golombek S, Vento M (2014). Ventilator-associated pneumonia in neonatal patients: an update. Neonatology. 105:98-107. |
|
Duffy LC (2000). Interactions mediating bacterial translocation in the immature intestine. J. Nutr. 130:432-436. |
|
Foglia E, Meier MD, Elward A (2007). Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients. Clin. Microbiol. Rev. 20:409-425. |
|
Forestier C, Guelon D, Cluytens V, Gillart T, Sirot J, De Champs C (2008). Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo controlled pilot study in intensive care unit patients. Crit. Care. 12(3):R69. |
|
Gluck U, Gebbers JO (2003). Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and β-hemolytic streptococci). Am. J. Clin. Nutr. 77:517-520. |
|
Griffiths EA, Duffy LC, Schanbacher FL, Qiao H, Dryja D, Leavens A, Rossman J, Rich G, Dirienzo D, Ogra PL (2004). In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig. Dis. Sci. 49:579-589. |
|
Hao Q, Lu Z, Dong BR, Huang CU, Wu T (2011). Probiotics for preventing acute upper respiratory tract infections. Cochrane Database of Systematic Reviews (9):CD006895. |
|
Hojsak I, Abdović S, Szajewska H, Milosević M, Krznarić Z, Kolacek S (2010). Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 125:1171-1177. |
|
Hojsak I, Tokić Pivac V, MoÄić Pavić A, Pasini AM, KolaÄek S (2015). Bifidobacterium animalis subsp. lactis fails to prevent common infections in hospitalized children: a randomized, double-blind, placebo-controlled study. Am. J. Clin. Nutr. 101:680-684. |
|
Honeycutt TC, El Khashab M, Wardrop III RM, McNeal-Trice K, Honeycutt AL, Christy CG, Mistry K, Harris BD, Meliones JN, Kocis KC. (2007). Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: A randomized placebo-controlled trial. Pediatr. Crit. Care Med. 8:452-458. |
|
Klarin B, Molin G, Jeppson B, Larsson A (2008). Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomized controlled open pilot study. Crit Care. 12(6):R136. |
|
Klingberg TD, and Budde BB (2006). The survival and persistence in the human gastrointestinal tract of five potential probiotic lactobacilli consumed as freeze-dried cultures or as probiotic sausage. Int. J. Food Microbiol. 109:157-159. |
|
McNabb B, Isakow W (2008). Probiotics for the prevention of nosocomial pneumonia. Curr. Opin. Pulm. Med. 14:168-175. |
|
Merenstein D, Murphy M, Fokar A, Hernandez RK, Park H, Nsouli H, Sanders ME, Davis BA, Niborski V, Tondu F, Shara NM (2010). Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patientoriented, double-blind, cluster-randomized, placebocontrolled, clinical trial. Eur. J. Clin. Nutr. 64(7):669-677. |
|
Mihatsch WA, Vossbeck S, Eikmanns B, Hoegel J, Pohlandt F (2010). Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial. Neonatology 98:156-163. |
|
Pitsouni E, Alexious V, Saridakis V, Peppas G, Falagas M (2009). Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Euro. J. Pharmacol. 65:561-570. |
|
Rautava S, Salminen S, Isolauri E (2009). Speciï¬c probiotics in reducing the risk of acute infections in infancy--a randomised, double-blind, placebo-controlled study. Br. J. Nutr. 101(11):1722-1726. |
|
Rerksuppaphol S, Rerksuppaphol L (2012). Randomized controlled trial of probiotics to reduce common cold in school children. Pediatr. Int. 54(5):682-687. |
|
Rio ME, Zago Beatriz L, Garcia H, Winter L (2002). The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children. Arch. Latinom Nutr. 52(1):29-34. |
|
Rojas MA, Lozano JM, Rojas MX, et al (2012). Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 130:1113-1120. |
|
Sanz JMC, Mateos JA, Conejo AM (2006). Effect of Lactobacillus casei on the incidence of infectious conditions in children. Nytr. Hosp. 21(4):547-551. |
|
Sohn AH, Garrett DO, Sinkowitz-Cochran RL, Grohskopf LA, Levine GL, Stover BH, Siegel JD, Jarvis WR (2001). Pediatric Prevention Network. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J. Pediatr. 139:821-827. |
|
Szajewska H (2011). Short- and long-term effects of probiotics administered early in life. Nestle Nutr. Workshop Ser. Pediatr. Program 68:65-78. |
|
Szajewska H, van Goudoever JB (2014). To give or not to give probiotics to preterm infants. Am. J. Clin. Nutr. 100:1411-1412. |
|
Taori RN, Lahiri KR, Tullu MS (2010). Performance of PRISM (Pediatric Risk of Mortality) score and PIM (Pediatric Index of Mortality) score in a tertiary care pediatric ICU. Indian J. Pediatr. 77:267-271. |
|
Wang YB, Du W, Fu AK, Zhang XP, Huang Y, Lee KH, Yu K, Li WF, Li YL (2016). Intestinal microbiota and oral administration of Enterococcus faecium associated with the growth performance of new-born piglets. Benef. Microbes. 19:1-10. |
|
Wolvers D, Antoine JM, Myllyluoma E, Schrezenmeir J, Szajewska H, Rijkers JT (2010). Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J. Nutr. 140:698-712. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0